Tumor shrinkage and depth of response of fruquintinib plus sintilimab in patients with advanced renal cell carcinoma: a post-hoc analysis from FRUSICA-2 (ESMO Asia 2026) - Oct 1, 2026 - Abstract #430P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Clinical • Metastases • Retrospective data • Genito-urinary Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor
|
|
Yuanyuan Qu; Zhisong He; Xiaodong Zhang; Xin Yao; Yu Xie; Jianming Guo; Jing Li; Bin Hu; Jiasheng Bian; Chaozhao Liang; Jun Xiao; Nianzeng Xing; Lulin Ma; Xiaoping Zhang; Zhenhua Liu; Xiaolin Lu; Shanshan Wang; Yu Zhu; Songhua Fan; Dingwei Ye
|